USL311
Cat.No:IU0810 Solarbio
CAS:1373268-67-7
Molecular Formula:C24H34N6O
Molecular Weight:422.57
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Immunology & Inflammation >
USL311CAS:1373268-67-7
Molecular Formula:C24H34N6O
Molecular Weight:422.57
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
CAS | 1373268-67-7 |
Name | USL311 |
Molecular Formula | C24H34N6O |
Molecular Weight | 422.57 |
Solubility | Soluble in DMSO ≥1mg/mL(Need ultrasonic) |
Purity | ≥98% |
Appearance | Light yellow to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
SMILES | CC(C)N1CCC(CC1)N2CCCN(CC2)C3=CC=CC(=N3)C(=O)NC4=CC=NC=C4 |
InChIKey | XNUNVQKARNSSEO-UHFFFAOYSA-N |
InChI | InChI=1S/C24H34N6O/c1-19(2)28-15-9-21(10-16-28)29-13-4-14-30(18-17-29)23-6-3-5-22(27-23)24(31)26-20-7-11-25-12-8-20/h3,5-8,11-12,19,21H,4,9-10,13-18H2,1-2H3,(H,25,26,31) |
PubChem CID | 56961879 |
Target Point | CXCR |
Passage | Immunology & Inflammation;GPCR & G Protein |
Background | USL311 is a potent and selective CXCR4 antagonist with anticancer activity. USL311 inhibits the binding of stromal cell derived factor-1 (SDF-1/CXCL12) to CXCR4. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.